FIBSAYLA Trademark

Trademark Overview

On Friday, January 1, 2016, a trademark application was filed for FIBSAYLA with the United States Patent and Trademark Office. The USPTO has given the FIBSAYLA trademark a serial number of 86863689. The federal status of this trademark filing is REGISTERED as of Tuesday, November 10, 2020. This trademark is owned by Gilead Sciences Ireland UC. The FIBSAYLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, immunological, oncological and hematological conditions, diseases and disorders; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia, and lymphoma; pharmaceutical preparations for the treatment of hepatitis
fibsayla

General Information

Serial Number86863689
Word MarkFIBSAYLA
Filing DateFriday, January 1, 2016
Status700 - REGISTERED
Status DateTuesday, November 10, 2020
Registration Number6192296
Registration DateTuesday, November 10, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, immunological, oncological and hematological conditions, diseases and disorders; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia, and lymphoma; pharmaceutical preparations for the treatment of hepatitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, January 5, 2016NEW APPLICATION ENTERED
Tuesday, January 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 5, 2016ASSIGNED TO EXAMINER
Thursday, April 7, 2016SUSPENSION LETTER WRITTEN
Thursday, April 7, 2016LETTER OF SUSPENSION E-MAILED
Thursday, April 7, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 7, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 19, 2017SUSPENSION INQUIRY WRITTEN
Wednesday, April 19, 2017INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 19, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, April 21, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, May 13, 2017ASSIGNED TO LIE
Monday, May 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 20, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2017SOU EXTENSION 1 FILED
Wednesday, December 13, 2017SOU EXTENSION 1 GRANTED
Friday, December 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 29, 2018SOU EXTENSION 2 FILED
Friday, June 29, 2018SOU EXTENSION 2 GRANTED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2018SOU TEAS EXTENSION RECEIVED
Monday, December 17, 2018SOU EXTENSION 3 FILED
Monday, December 17, 2018SOU EXTENSION 3 GRANTED
Wednesday, December 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019SOU EXTENSION 4 FILED
Tuesday, June 25, 2019SOU EXTENSION 4 GRANTED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 8, 2020SOU TEAS EXTENSION RECEIVED
Monday, January 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 8, 2020SOU EXTENSION 5 FILED
Monday, January 13, 2020SOU EXTENSION 5 GRANTED
Tuesday, January 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2020TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, August 4, 2020NOTICE OF ALLOWANCE CANCELLED
Saturday, October 3, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 10, 2020REGISTERED-PRINCIPAL REGISTER
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 10, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

fibsayla preparations pharmaceutical treatment diseases anti infectious fibrotic prevention myeloma hepatitis